"Visit Bon Secours Liver Institute of Richmond in Richmond, Virginia. Bon Secours Liver Institute of Richmond is one of the many Liver Care Hepatology locations at Bon Secours providing good help to those in need."

During the past decade, Bon Secours Liver Institute of Richmond conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 14 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 10 clinical trials were completed. i.e. 111.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bon Secours Liver Institute of Richmond" #1 sponsor was "Gilead Sciences" with 12 trials, followed by "Target PharmaSolutions, Inc." with 5 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Intercept Pharmaceuticals" with 2 trials sponsored and "Madrigal Pharmaceuticals, Inc." with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bon Secours Liver Institute of Richmond" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Chronic Liver Disease Foundation" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Novo Nordisk A/S" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Bon Secours Liver Institute of Richmond" are "Nonalcoholic Steatohepatitis" (7 trials), "Hepatitis C Virus Infection" (3 trials), "Primary Biliary Cirrhosis" (3 trials), "Hepatitis C" (2 trials) and "Hepatitis C, Chronic" (2 trials). Many other conditions were trialed in "Bon Secours Liver Institute of Richmond" in a lesser frequency.

Most popular intervention types in "Bon Secours Liver Institute of Richmond" are "Drug" (27 trials), "Other" (3 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "SEL" (3 trials), "SOF/VEL" (3 trials), "BMS-986036" (2 trials) and "CILO" (2 trials). Other intervention names were less common.

The vast majority of trials in "Bon Secours Liver Institute of Richmond" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Bon Secours Liver Institute of Richmond". undefined are not yet recruiting, 7 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Bon Secours Liver Institute of Richmond, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Bon Secours Liver Institute of Richmond, 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".